Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Investing Activities ₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr₹-439 Cr₹-444 Cr

What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Investing Activities ratio of MANKIND PHARMA is ₹-1,054 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Investing Activities
Mar2023₹-1,054 Cr
Mar2022₹-1,369 Cr
Mar2021₹-1,222 Cr
Mar2020₹-439 Cr
Mar2019₹-444 Cr

How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2023 ₹-1,054 Cr
Negative
Mar2022 ₹-1,369 Cr
Negative
Mar2021 ₹-1,222 Cr
Negative
Mar2020 ₹-439 Cr
Negative
Mar2019 ₹-444 Cr -

Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹82,661.8 Cr -2.3% -14% 57.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.3%

-14%

57.7%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses